CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer

Colorectal cancer (CRC) is ranked as the third most common cancer and second deadliest cancer in both men and women in the world. Currently, the cure rate and 5-year survival rate of CRC patients remain relatively low. Therefore, discovering a novel molecular biomarker that can be used to improve CRC screening, diagnosis, prognosis, and treatment would be beneficial. Long non-coding RNA colon cancer-associated transcript 1 (CCAT 1) has been found overexpressed in CRC and is associated with CRC tumorigenesis and treatment outcome. CCAT 1 has a high degree of specificity and sensitivity, it is readily detected in CRC tissues and is significantly overexpressed in both premalignant and malignant CRC tissues. Besides, CCAT 1 is associated with clinical manifestation and advanced features of CRC, such as lymph node metastasis, high tumor node metastasis stage, differentiation, invasion, and distant metastasis. In addition, they can upregulate oncogenic c-MYC and negatively modulate microRNAs via different mechanisms of action. Furthermore, dysregulated CCAT 1 also enhances the chemoresistance in CRC cells while downregulation of them reverses the malignant phenotypes of cancer cells. In brief, CCAT 1 serves as a potential screening, diagnostic and prognostic biomarker in CRC, it also serves as a potential therapeutic marker to treat CRC patients.

[1]  Hui Zhou,et al.  CREB1 contributes colorectal cancer cell plasticity by regulating lncRNA CCAT1 and NF-κB pathways , 2020, bioRxiv.

[2]  Jun Li,et al.  Knockdown of lncRNA CCAT1 Inhibits the Progression of Colorectal Cancer via hsa-miR-4679 Mediating the Downregulation of GNG10 , 2021, Journal of immunology research.

[3]  S. Cai,et al.  Transcriptomic Analyses of the Adenoma-Carcinoma Sequence Identify Hallmarks Associated With the Onset of Colorectal Cancer , 2021, Frontiers in Oncology.

[4]  S. Rozen,et al.  Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis , 2021, Scientific reports.

[5]  Lei Zhao,et al.  Effect of rs67085638 in long non‐coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA‐24‐3p and FSCN1 , 2020, Journal of cellular and molecular medicine.

[6]  Jun Liu,et al.  Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo. , 2020, Journal of gastrointestinal oncology.

[7]  Leon N. Schulte,et al.  Disease-Causing Mutations and Rearrangements in Long Non-coding RNA Gene Loci , 2020, Frontiers in Genetics.

[8]  M. Hashemi,et al.  Identification of a stool long non‐coding RNAs panel as a potential biomarker for early detection of colorectal cancer , 2020, Journal of clinical laboratory analysis.

[9]  Dong Li,et al.  Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression , 2020, Aging.

[10]  C. Cardwell,et al.  Change in public awareness of colorectal cancer symptoms following the Be Cancer Alert Campaign in the multi-ethnic population of Malaysia , 2020, BMC Cancer.

[11]  Jing-Yuan Fang,et al.  Comprehensive review of targeted therapy for colorectal cancer , 2020, Signal Transduction and Targeted Therapy.

[12]  Jinhui Yang,et al.  Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1 , 2020, Cancer biology & therapy.

[13]  Ming Zhou,et al.  Long non-coding RNA CCAT1 promotes colorectal cancer cell migration, invasiveness and viability by upregulating VEGF via negative modulation of microRNA-218 , 2020, Experimental and therapeutic medicine.

[14]  Nuno A. Fonseca,et al.  Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis , 2020, Communications Biology.

[15]  I. Csabai,et al.  Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition , 2019, BMC Cancer.

[16]  Yan Liu,et al.  LncRNA CCAT1 Promotes Colorectal Cancer Tumorigenesis Via A miR-181b-5p/TUSC3 Axis , 2019, OncoTargets and therapy.

[17]  Jiandong Shi,et al.  Comprehensive Analysis of the Expression Profiles of Long Non-Coding RNAs with Associated ceRNA Network Involved in the Colon Cancer Staging and Progression , 2019, Scientific Reports.

[18]  F. Zheng,et al.  The Reciprocal Interaction Between LncRNA CCAT1 and miR-375-3p Contribute to the Downregulation of IRF5 Gene Expression by Solasonine in HepG2 Human Hepatocellular Carcinoma Cells , 2019, Front. Oncol..

[19]  Nashwa El-Khazragy,et al.  Assessment of The Lnc-CCAT1/miR-155a Regulatory Network in Acute Myeloid Leukemia , 2019, Clinical Oncology and Research.

[20]  P. Golusiński,et al.  MicroRNA regulation in colorectal cancer tissue and serum , 2019, PloS one.

[21]  Yiduo Wang,et al.  LncRNA CCAT1 Promotes Prostate Cancer Cell Proliferation by Interacting with DDX5 and MIR-28-5P , 2019, Molecular Cancer Therapeutics.

[22]  H. Choudhry,et al.  Long Noncoding RNAs as Prognostic Markers for Colorectal Cancer in Saudi Patients. , 2019, Genetic testing and molecular biomarkers.

[23]  Sanjeev Raghuwanshi,et al.  Long non-coding RNA: Classification, biogenesis and functions in blood cells. , 2019, Molecular immunology.

[24]  S. Hann,et al.  The functions and oncogenic roles of CCAT1 in human cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  R. Wu,et al.  lncRNA-PCAT1 rs2632159 polymorphism could be a biomarker for colorectal cancer susceptibility , 2019, Bioscience reports.

[26]  H. Yamawaki,et al.  Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer , 2019, International journal of molecular sciences.

[27]  Yong Pan,et al.  Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells , 2019, BMC Molecular and Cell Biology.

[28]  Fangfang Guo,et al.  CCAT1 lncRNA Promotes Inflammatory Bowel Disease Malignancy by Destroying Intestinal Barrier via Downregulating miR-185-3p. , 2019, Inflammatory bowel diseases.

[29]  E. Rudolf,et al.  Selected Aspects of Chemoresistance Mechanisms in Colorectal Carcinoma—A Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and Apoptosis , 2019, Cells.

[30]  Jinliang Li,et al.  Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1. , 2019, Experimental and molecular pathology.

[31]  N. Senzer,et al.  Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy , 2019, Future science OA.

[32]  J. Rui,et al.  miR-410 acts as an oncogene in colorectal cancer cells by targeting dickkopf-related protein 1 via the Wnt/β-catenin signaling pathway , 2018, Oncology letters.

[33]  Hanchen Xu,et al.  Drug resistance and new therapies in colorectal cancer , 2018, World journal of gastroenterology.

[34]  Han Liu,et al.  Upregulation of long noncoding RNA CCAT1-L promotes epithelial–mesenchymal transition in gastric adenocarcinoma , 2018, OncoTargets and therapy.

[35]  Wei Cheng,et al.  Overexpression of the long noncoding RNA CCAT1 promotes metastasis via epithelial-to-mesenchymal transition in lung adenocarcinoma. , 2018, Oncology letters.

[36]  Ville Mustonen,et al.  The evolutionary landscape of colorectal tumorigenesis , 2018, Nature Ecology & Evolution.

[37]  T. Ochiya,et al.  Emerging roles of long non‐coding RNA in cancer , 2018, Cancer science.

[38]  A. Magnano,et al.  LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions , 2018, Molecular therapy. Nucleic acids.

[39]  Haibiao Xie,et al.  Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis , 2018, Oncotarget.

[40]  C. Fan,et al.  Long noncoding RNA CCAT1 polymorphisms are associated with the risk of colorectal cancer. , 2018, Cancer genetics.

[41]  A. Shaw,et al.  Tumour heterogeneity and resistance to cancer therapies , 2018, Nature Reviews Clinical Oncology.

[42]  Pran K. Datta,et al.  Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis , 2017, Cancers.

[43]  Bo Li,et al.  Long noncoding RNA CCAT1 functions as a ceRNA to antagonize the effect of miR-410 on the down-regulation of ITPKB in human HCT-116 and HCT-8 cells , 2017, Oncotarget.

[44]  Yuchen Liu,et al.  Colon cancer associated transcripts in human cancers. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[45]  Huirong Shi,et al.  Long non‐coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer , 2017, Experimental cell research.

[46]  C. Maher,et al.  The potential use of lncRNAs found in the 8q24 region as biomarkers for colon cancer. , 2017, Annals of Oncology.

[47]  G. Calin,et al.  CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 ‘gene desert’, serve as important prognostic biomarkers in colorectal cancer , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[48]  I. Iaccarino.  lncRNAs and MYC: An Intricate Relationship , 2017, International journal of molecular sciences.

[49]  F. Gao,et al.  Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis , 2017, PloS one.

[50]  Kaixiang Xu,et al.  Low-Dose Paclitaxel Inhibits Tumor Cell Growth by Regulating Glutaminolysis in Colorectal Carcinoma Cells , 2017, Front. Pharmacol..

[51]  Xiaoqiang Guo,et al.  CCAT1: an oncogenic long noncoding RNA in human cancers , 2017, Journal of Cancer Research and Clinical Oncology.

[52]  J. Wind,et al.  Symptomatic and Asymptomatic Colon Cancer Recurrence: A Multicenter Cohort Study , 2016, The Annals of Family Medicine.

[53]  Howard Y. Chang,et al.  Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.

[54]  W. Wang,et al.  Long Non-Coding RNA CCAT1 Acts as a Competing Endogenous RNA to Regulate Cell Growth and Differentiation in Acute Myeloid Leukemia , 2016, Molecules and cells.

[55]  Oleg Mayba,et al.  CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. , 2016, The Journal of clinical investigation.

[56]  B. Tang,et al.  Long non-coding RNAs in colorectal cancer , 2015, Oncotarget.

[57]  Xiang Li,et al.  Long non-coding RNA CCAT1 that can be activated by c-Myc promotes pancreatic cancer cell proliferation and migration. , 2016, American journal of translational research.

[58]  Jie Zhang,et al.  Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma. , 2015, International journal of clinical and experimental pathology.

[59]  S. Pileri,et al.  Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation , 2015, BMC Cancer.

[60]  H. Lee,et al.  c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer , 2015, PloS one.

[61]  Ting Liu,et al.  Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer. , 2015, International journal of clinical and experimental pathology.

[62]  Xuebing Yan,et al.  N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer. , 2015, Molecular medicine reports.

[63]  Ming Zhou,et al.  Expression of lncRNA-CCAT1, E-cadherin and N-cadherin in colorectal cancer and its clinical significance. , 2015, International journal of clinical and experimental medicine.

[64]  Shicong Yang,et al.  Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge , 2015, Journal of experimental & clinical cancer research : CR.

[65]  Alexander Stojadinovic,et al.  Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the Stomach , 2015, Journal of Cancer.

[66]  Yan Zhang,et al.  Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p , 2015, Cell Death and Disease.

[67]  R. Lothe,et al.  Portrait of the PI3K/AKT pathway in colorectal cancer. , 2015, Biochimica et biophysica acta.

[68]  Li Liu,et al.  Regulation of lncRNA expression , 2014, Cellular & Molecular Biology Letters.

[69]  A. Stojadinovic,et al.  Detection of a long non-coding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FIT-PNA molecular beacons. , 2014, Cancer letters.

[70]  Limei Ma,et al.  C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion , 2014, Tumor Biology.

[71]  L. Tang,et al.  Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer , 2014, Tumor Biology.

[72]  M. Cole.  MYC association with cancer risk and a new model of MYC-mediated repression. , 2014, Cold Spring Harbor perspectives in medicine.

[73]  Junhui Ge,et al.  Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus , 2014, Cell Research.

[74]  C. Croce,et al.  Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5 , 2014, Proceedings of the National Academy of Sciences.

[75]  J. Foekens,et al.  CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer , 2013, Genome research.

[76]  E. Kuipers,et al.  Colorectal cancer screening—optimizing current strategies and new directions , 2013, Nature Reviews Clinical Oncology.

[77]  B. Trink,et al.  Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence , 2013, BMC Cancer.

[78]  A. Schetter,et al.  The Role of MicroRNAs in Colorectal Cancer , 2012, Cancer journal.

[79]  N. Caplen,et al.  The 8q24 Gene Desert: An Oasis of Non-Coding Transcriptional Activity , 2012, Front. Gene..

[80]  Gerd Ritter,et al.  Colon cancer associated transcript‐1: A novel RNA expressed in malignant and pre‐malignant human tissues , 2012, International journal of cancer.

[81]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[82]  M. Freedman,et al.  Chromosome 8q24-Associated Cancers and MYC. , 2010, Genes & cancer.

[83]  Jimmy Lin,et al.  Novel somatic mutations in heterotrimeric G proteins in melanoma , 2010, Cancer biology & therapy.

[84]  Christopher A. Haiman,et al.  The 8q24 cancer risk variant rs6983267 demonstrates long-range interaction with MYC in colorectal cancer , 2009, Nature Genetics.

[85]  G. Blobel,et al.  Chromatin loops in gene regulation. , 2009, Biochimica et biophysica acta.

[86]  J. Blenis,et al.  Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1 , 2008, Proceedings of the National Academy of Sciences.

[87]  E. D. de Vries,et al.  Prognostic versus predictive value of biomarkers in oncology. , 2008, European journal of cancer.

[88]  Steven Gallinger,et al.  Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24 , 2007, Nature Genetics.

[89]  Peter Carmeliet,et al.  VEGF as a Key Mediator of Angiogenesis in Cancer , 2005, Oncology.